Cafusertib Hydrochloride
盐酸卡呋色替
Report date: 2022/07/19 16:22:54
NME
Base Information
Drug NameCafusertib Hydrochloride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesJiangsu Hansoh Pharmaceutical Group Co LtdJiangsu Haosen Medical Research Institute Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A